Sign In
Buy ATRA
$9.63
-0.270 (-2.73%)
At Close: Jun 03, 2026
Atara Biotherapeutics: Still Bullish On Long-Term Prospects
04:43am, Tuesday, 14'th Apr 2020
Atara Biotherapeutics recently updated that its lead program, tab-cel, remains on track despite the COVID-19 pandemic. Tab-cel is the most advanced allogeneic T
Analysts' Top Healthcare Picks: VBI Vaccines (VBIV), Irhythm Technologies (IRTC)
10:05am, Monday, 13'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on VBI Vaccines (VBIV) and Irhythm Technologies (IRTC) with
Analysts’ Top Healthcare Picks: VBI Vaccines (VBIV), Irhythm Technologies (IRTC)
10:05am, Monday, 13'th Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on VBI Vaccines
Atara Biotherapeutics Inc (NASDAQ:ATRA) Position Reduced by UBS Asset Management Americas Inc.
10:38am, Sunday, 12'th Apr 2020
UBS Asset Management Americas Inc. trimmed its position in Atara Biotherapeutics Inc (NASDAQ:ATRA) by 87.4% in the fourth quarter, according to its most recent disclosure with the Securities and Excha
Atara Biotherapeutics (NASDAQ:ATRA) Trading Up 10.2%
09:42am, Saturday, 11'th Apr 2020
Atara Biotherapeutics Inc (NASDAQ:ATRA)’s share price was up 10.2% during trading on Thursday . The company traded as high as $8.81 and last traded at $8.55, approximately 1,449,300 shares were trad
Beth Seidenberg
02:49pm, Friday, 10'th Apr 2020
Beth Seidenberg, founding managing director of Westlake Village BioPartners, is one of Barron’s 100 Most Influential Women in U.S. Finance in 2020. Read more about her career and accomplishments her
Beth Seidenberg
01:00pm, Friday, 10'th Apr 2020
Beth Seidenberg, founding managing director of Westlake Village BioPartners, is one of Barron’s 100 Most Influential Women in U.S. Finance in 2020. Read more about her career and accomplishments her
Reviewing Idera Pharmaceuticals (NASDAQ:IDRA) and Atara Biotherapeutics (NASDAQ:ATRA)
05:16am, Friday, 10'th Apr 2020
Idera Pharmaceuticals (NASDAQ:IDRA) and Atara Biotherapeutics (NASDAQ:ATRA) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the s
Analysts Offer Insights on Healthcare Companies: Incyte (INCY), SAGE Therapeutics (SAGE) and Pfenex (PFNX)
07:37pm, Thursday, 09'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Incyte (INCY), SAGE Therapeutics (SAGE) and Pfenex (PFNX)
Analysts Offer Insights on Healthcare Companies: Incyte (NASDAQ: INCY), SAGE Therapeutics (NASDAQ: SAGE) and Pfenex (NYSE MKT: PFNX)
07:37pm, Thursday, 09'th Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Incyte (
INCY
–
Research Report
), SAGE Therapeutics (
SAGE
–
Research Report
) and Pfenex (
PFNX
�
56 Stocks Moving In Tuesday's Mid-Day Session
04:47pm, Tuesday, 07'th Apr 2020
Gainers
Borr Drilling, Inc. (NYSE: BORR) shares jumped 70.9% to $1.3499 after surging over 37% on Monday.
Sasol Limited (NYSE: SSL) shares surged 63.4% to $4.15 amid hopes of...
Goldman Sachs Group Inc. Acquires 20,589 Shares of Atara Biotherapeutics Inc (NASDAQ:ATRA)
09:58am, Tuesday, 07'th Apr 2020
Goldman Sachs Group Inc. grew its holdings in Atara Biotherapeutics Inc (NASDAQ:ATRA) by 5.1% during the 4th quarter, HoldingsChannel.com reports. The firm owned 422,532 shares of the biotechnology co
Assembly Biosciences (ASMB) Receives a Buy from Mizuho Securities
05:46pm, Monday, 06'th Apr 2020
In a report released today, Salim Syed from Mizuho Securities maintained a Buy rating on Assembly Biosciences (ASMB), with a price target of $30.00. The
Assembly Biosciences (ASMB) Receives a Buy from Mizuho Securities
05:46pm, Monday, 06'th Apr 2020
In a report released today,
Salim Syed
from Mizuho Securities maintained a
Buy
rating on Assembly Biosciences (
ASMB
–
Research Report
), with a price target of
$30.00
. The company’s shares close
